Form D Explorer

Nula Therapeutics, Inc. research brief

CIK 2121301

Generated Nov. 17, 2026, 8:35 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: St. Petersburg Florida. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

Reviewed offering links

Citation: Form D Explorer, “Nula Therapeutics, Inc. research brief,” CIK 2121301, retrieved Nov. 17, 2026, 8:35 p.m.. Cite the specific accessions used. No amounts have been summed.